| Literature DB >> 30166909 |
Sanja Petrović1, Ana Tačić1, Saša Savić1, Vesna Nikolić1, Ljubiša Nikolić1, Sanela Savić2,3.
Abstract
The main goal of this study was to develop a liposome formulation with sulfanilamide and to investigate the liposomes impact on its release and stability to the UV-A/UV-B and UV-C irradiation. Liposome dispersions with incorporated sulfanilamide were prepared by thin-film hydration method and liposomes role to the sulfanilamide release was investigated by using a dialysis method. Comparatively, sulfanilamide in phosphate buffer solution was subject to release study as well to the UV irradiation providing for the possibilities of kinetics analysis. In vitro drug release study demonstrated that 20% of sulfanilamide was released from liposomes within 1 h that is approximately twice as slower as in the case of dissolved sulfanilamide in phosphate buffer solution. The kinetic release process can be described by Korsmeyer-Peppas model and according to the value of diffusion release exponent it can be concluded that drug release mechanism is based on the phenomenon of diffusion. The sulfanilamide degradation in phosphate buffer solution and liposomes is related to the formation of UV-induced degradation products that are identified by UHPLC/MS analysis as: sulfanilic acid, aniline and benzidine. The UV-induced sulfanilamide degradation in the phosphate buffer solution and liposome vesicles fits the first- order kinetic model. The degradation rate constants are dependent on the involved UV photons energy input as well as sulfanilamide microenvironment. Liposome microenvironment provides better irradiation sulfanilamide stability. The obtained results suggest that liposomes might be promising carriers for delayed sulfanilamide delivery and may serve as a basis for further research.Entities:
Keywords: Degradation; Irradiation; Liposomes; Release; Stability; Sulfanilamide
Year: 2017 PMID: 30166909 PMCID: PMC6111141 DOI: 10.1016/j.jsps.2017.09.003
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
Fig. 1UV–Vis spectra of SA incorporated in PC-SUV/LUV and MLV liposomes joined with the SA-PBS spectra. The SA concentration was 1 × 10−5 M. The final SA/lipid ratio was 1/50.
Fig. 2Sulfanilamide release profiles from PBS and liposomes.
In vitro SA release kinetics models.
| Kinetic model | Parameter | SA in liposomes | SA in PBS |
|---|---|---|---|
| Zero order | 0.228 | 0.651 | |
| R2 | −0.2091 | 0.0241 | |
| AIC | 56.3222 | 52.2794 | |
| First order | 0.003 | 0.010 | |
| R2 | −0.0854 | 0.3657 | |
| AIC | 55.3514 | 49.2628 | |
| Korsmeyer–Peppas | 6.634 | 17.472 | |
| n | 0.236 | 0.207 | |
| R2 | 0.9254 | 0.998 | |
| AIC | 33.2504 | 10.7935 | |
| Baker–Lonsdale | 0 | 0.001 | |
| R2 | 0.7102 | 0.8672 | |
| AIC | 43.4663 | 38.32 | |
| Higuchi | 2.216 | 5.489 | |
| R2 | 0.6833 | 0.8123 | |
| AIC | 44.2654 | 40.739 | |
R2, coefficient of determination; AIC, Akaike Information Criterion; F is the fraction of drug released at time t; k0 is the zero-order release constant; k1 is the first-order release constant; kKP is the release constant incorporating structural and geometric characteristics of the drug-dosage form; n is diffusion release exponent; kBL is the combined constant in Baker-Lonsdale model; kH is the Higuchi release constant (Costa and Lobo, 2001, Zhang et al., 2010, Đordevic et al., 2016).
Fig. 3SA degradation (%) in SUV/LUV/MLV liposomes and in PBS induced by UV-A (A), UV-B (B) and UV-C (C) irradiation as a function of UV irradiation time. SA concentration in liposomes and in PBS was 1 × 10−5 M. In the Figures inserts are represented corresponding lnC/C = f(tirr.) graphs.
Rate constants, k (min−1), calculated from the slopes of the corresponding kinetic logarithmic plots lnC/C = f(tirr.).
| Medium | UV-irradiation wavelength, nm | ||
|---|---|---|---|
| UV-A (350 nm) | UV-B (300 nm) | UV-C (254 nm) | |
| SUV (100 nm) | 0.00201 | 0.00280 | 0.01985 |
| LUV (400 nm) | 0.00191 | 0.00259 | 0.02099 |
| MLV (1000 nm) | 0.00162 | 0.00227 | 0.01278 |
| PBS | 0.00202 | 0.00477 | 0.03616 |
Fig. 4UHPLC chromatograms of sulfanilamide (A) and sulfanilamide after UV-A (B), UV-B (C) and UV-C irradiation (D). SA concentration was 1 × 10−5 M.
Characteristic parameters of identified compounds after UV irradiation of SA.
| Peak No | t | Molar mass | [M + H]+ | MS/MS | Compound | Molecular structure | |
|---|---|---|---|---|---|---|---|
| 1 | 1.01 | 172.03 | 173.61 | 155.97 | 262 | Sulfanilamide | |
| 125.03 | |||||||
| 108.02 | |||||||
| 93.06 | |||||||
| 2 | 1.51 | 173.01 | 174.03 | 156.01 | 249 | Sulfanilic acid | |
| 108.02 | |||||||
| 93.03 | |||||||
| 3 | 1.19 | 93.05 | 94.05 | 81.03 | 232 | Aniline | |
| 77.03 | 284 | ||||||
| 51.02 | |||||||
| 4 | 0.82 | 184.01 | 185.01 | 180.68 | 286 | Benzidine | |
| 166.94 | |||||||
| 142.52 | |||||||
| 102.21 | |||||||